These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35692348)

  • 41. Estimation with interval censored data and covariates.
    Van der Laan MJ; Hubbard A
    Lifetime Data Anal; 1997; 3(1):77-91. PubMed ID: 9384627
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A regression-based method for estimating mean treatment cost in the presence of right-censoring.
    Carides GW; Heyse JF; Iglewicz B
    Biostatistics; 2000 Sep; 1(3):299-313. PubMed ID: 12933511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction in censored survival data: a comparison of the proportional hazards and linear regression models.
    Heller G; Simonoff JS
    Biometrics; 1992 Mar; 48(1):101-15. PubMed ID: 1581480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival forests for data with dependent censoring.
    Moradian H; Larocque D; Bellavance F
    Stat Methods Med Res; 2019 Feb; 28(2):445-461. PubMed ID: 28835170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Semiparametric analysis of survival data with left truncation and dependent right censoring.
    Jiang H; Fine JP; Chappell R
    Biometrics; 2005 Jun; 61(2):567-75. PubMed ID: 16011706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estimation of median survival time and its 95% confidence interval using SAS PROC LIFETEST.
    Talsma PA
    J Biopharm Stat; 2024 May; 34(3):366-378. PubMed ID: 37144552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonparametric estimation of transition probabilities in the non-Markov illness-death model: A comparative study.
    de Uña-Álvarez J; Meira-Machado L
    Biometrics; 2015 Jun; 71(2):364-75. PubMed ID: 25735883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bias-adjusted Kaplan-Meier survival curves for marginal treatment effect in observational studies.
    Wang X; Bai F; Pang H; George SL
    J Biopharm Stat; 2019; 29(4):592-605. PubMed ID: 31286838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Robust versus consistent variance estimators in marginal structural Cox models.
    Enders D; Engel S; Linder R; Pigeot I
    Stat Med; 2018 Oct; 37(24):3455-3470. PubMed ID: 29888510
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Accurate confidence limits for quantiles under random censoring.
    Strawderman RL; Parzen MI; Wells MT
    Biometrics; 1997 Dec; 53(4):1399-415. PubMed ID: 9423256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bayesian nonparametric inference on quantile residual life function: Application to breast cancer data.
    Park T; Jeong JH; Lee JW
    Stat Med; 2012 Aug; 31(18):1972-85. PubMed ID: 22437758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Robust Wald-type tests under random censoring.
    Ghosh A; Basu A; Pardo L
    Stat Med; 2021 Feb; 40(5):1285-1305. PubMed ID: 33372282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimating and comparing adverse event probabilities in the presence of varying follow-up times and competing events.
    Stegherr R; Schmoor C; Lübbert M; Friede T; Beyersmann J
    Pharm Stat; 2021 Nov; 20(6):1125-1146. PubMed ID: 34002935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. On hazard ratio estimators by proportional hazards models in matched-pair cohort studies.
    Shinozaki T; Mansournia MA; Matsuyama Y
    Emerg Themes Epidemiol; 2017; 14():6. PubMed ID: 28592984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exploring the Effects of Early Censoring and Analysis of Clinical Trial Survival Data on Effectiveness and Cost-effectiveness Estimation through a Case Study in Advanced Breast Cancer.
    Bagust A; Beale SJ
    Med Decis Making; 2018 Oct; 38(7):789-796. PubMed ID: 30125510
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimation of colorectal adenoma recurrence with dependent censoring.
    Hsu CH; Long Q; Alberts DS
    BMC Med Res Methodol; 2009 Sep; 9():66. PubMed ID: 19788750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Visualizing length of survival in time-to-event studies: a complement to Kaplan-Meier plots.
    Royston P; Parmar MK; Altman DG
    J Natl Cancer Inst; 2008 Jan; 100(2):92-7. PubMed ID: 18182621
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison between Kaplan-Meier and weighted Kaplan-Meier methods of five-year survival estimation of patients with gastric cancer.
    Zare A; Mahmoodi M; Mohammad K; Zeraati H; Hosseini M; Holakouie Naieni K
    Acta Med Iran; 2014; 52(10):764-7. PubMed ID: 25369011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An adjustment to improve the bivariate survivor function repaired NPMLE.
    Moodie FZ; Prentic RL
    Lifetime Data Anal; 2005 Sep; 11(3):291-307. PubMed ID: 16133881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nonparametric estimation of the mean function of a stochastic process with missing observations.
    Hu XJ; Lagakos SW
    Lifetime Data Anal; 2007 Mar; 13(1):51-73. PubMed ID: 17195105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.